PARATEK PHARMACEUTICALS INC (PRTK) Forecast, Price Target & Analyst Ratings

NASDAQ:PRTK • US6993743029

Current stock price

2.23 USD
+0.04 (+1.83%)
At close:
2.23 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PARATEK PHARMACEUTICALS INC (PRTK).

Forecast Snapshot

Consensus Price Target

Price Target
$3.16
+ 41.79% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 1, 2023
Period
Q3 / 2023
EPS Estimate
-$0.25
Revenue Estimate
39.602M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.16
Upside
+ 41.79%
From current price of $2.23 to mean target of $3.16, Based on 9 analyst forecasts
Low
$2.17
Median
$2.19
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
-41.87%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for PRTK. The average price target is 3.16 USD. This implies a price increase of 41.79% is expected in the next year compared to the current price of 2.23.
The average price target has been revised downward by 41.87% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PRTK Current Analyst RatingPRTK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

PRTK Historical Analyst RatingsPRTK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
PRTK was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PRTK.
In the previous month the buy percentage consensus was at a similar level.
PRTK was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-07HC Wainwright & Co.Reiterate Neutral -> Neutral
2023-07-10HC Wainwright & Co.Reiterate Neutral -> Neutral
2023-06-07JefferiesDowngrade Buy -> Hold
2023-06-07HC Wainwright & Co.Downgrade Buy -> Neutral
2023-03-20HC Wainwright & Co.Maintains Buy
2022-05-06HC Wainwright & Co.Maintains Buy
2022-02-10WBB SecuritiesUpgrade Buy -> Strong Buy
2021-11-09HC Wainwright & Co.Maintains Buy
2021-06-21HC Wainwright & Co.Maintains Buy
2021-04-23WBB SecuritiesUpgrade Speculative Buy -> Buy
2021-03-02JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 1, 2023
Period
Q3 / 2023
EPS Estimate
-$0.25
Revenue Estimate
39.602M
Revenue Q2Q
31.08%
EPS Q2Q
34.24%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
1.68%
EPS (1 Month)
0.00%
EPS (3 Months)
6.96%

Next Earnings Summary

PRTK is expected to report earnings on 11/1/2023. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 39.60M USD.
The next earnings revenue estimate has been revised upward by 1.68% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PRTK revenue by date.PRTK revenue by date.
46.92M
183.68%		130.162M
177.41%		160.268M
23.13%		166.13M
3.66%		237M
42.66%		225.85M
-4.70%		368.47M
63.15%		418.25M
13.51%		550.37M
31.59%		507.98M
-7.70%		533.31M
4.99%
EBITDA
YoY % growth
PRTK ebitda by date.PRTK ebitda by date.
-74.92M
41.97%		-40.739M
45.62%		-45.719M
-12.22%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PRTK ebit by date.PRTK ebit by date.
-75.5M
34.71%		-41.13M
45.52%		-46.209M
-12.35%		-36.641M
20.71%		14.696M
140.11%		21.643M
47.27%		141.78M
555.08%		184.07M
29.83%		298.87M
62.37%		148.34M
-50.37%		92.596M
-37.58%
Operating Margin
PRTK operating margin by date.PRTK operating margin by date.
-160.91%-31.60%-28.83%-22.06%6.20%9.58%38.48%44.01%54.30%29.20%17.36%
EPS
YoY % growth
PRTK eps by date.PRTK eps by date.
-2.25
42.75%		-1.22
45.78%		-1.18
3.28%		-0.80
32.14%		0.00
100.00%		0.031.80
5,783.33%		2.36
30.88%		3.23
37.23%		1.34
-58.68%		0.75
-43.51%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.25
34.24%		-0.04
66.00%		-0.18
47.54%		-0.13
46.96%		-0.10
59.18%		0.43
1,150.00%
Revenue
Q2Q % growth		39.602M
31.08%		53.841M
-28.74%		46.053M
47.44%		49.113M
22.80%		51.153M
29.17%		91.251M
69.48%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-9.91M
39.91%		3.463M
222.07%		-5.967M
62.25%		-3.481M
63.01%		-1.824M
81.60%		31.617M
812.99%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PRTK Yearly Revenue VS EstimatesPRTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
PRTK Yearly EPS VS EstimatesPRTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 2026 2027 2028 2029 2030 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.53%
EPS Next 5 Year
31.93%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
14.33%
Revenue Next 5 Year
22.58%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PARATEK PHARMACEUTICALS INC / PRTK Forecast FAQ

What is the average price target for PARATEK PHARMACEUTICALS INC (PRTK) stock?

9 analysts have analysed PRTK and the average price target is 3.16 USD. This implies a price increase of 41.79% is expected in the next year compared to the current price of 2.23.

What is the next earnings date for PRTK stock?

PARATEK PHARMACEUTICALS INC (PRTK) will report earnings on 2023-11-01, before the market open.

What are the consensus estimates for PARATEK PHARMACEUTICALS INC (PRTK) next earnings?

The consensus EPS estimate for the next earnings of PARATEK PHARMACEUTICALS INC (PRTK) is -0.25 USD and the consensus revenue estimate is 39.60M USD.

How do analysts rate PARATEK PHARMACEUTICALS INC (PRTK)?

The consensus rating for PARATEK PHARMACEUTICALS INC (PRTK) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.